New York State Common Retirement Fund Akebia Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 79,100 shares of AKBA stock, worth $262,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,100
Previous 38,400
105.99%
Holding current value
$262,612
Previous $74,000
289.19%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AKBA
# of Institutions
174Shares Held
103MCall Options Held
113KPut Options Held
277K-
Vanguard Group Inc Valley Forge, PA14.6MShares$48.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$26.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$20.2 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$19.1 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $610M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...